David Evans, Chairman
David has a proven track record in acquiring, integrating and growing businesses in the diagnostic area and in value creation, exemplified by his role at BBI Holdings Plc where he grew the company through acquisition and organic growth, from a value of £4million to a value of £84million in 2007, when BBI was sold to Inverness Medical Innovations Inc. He was Chairman of DxS Limited, which was sold in 2009 for £82million. David was also Chairman of Sirigen Group Limited, an early stage medical technology company that was sold in 2012 to Becton, Dickinson and Company, a global medical technology company. David was also previously Chairman of Immunodiagnostics Systems Holdings Plc, EKF Diagnostics Holdings Plc, Epistem Holdings Plc, Scancell Holdings Plc, OptiBiotix Health Plc and Premaitha Health Plc.
David is currently Chairman of Omega Diagnostics Group Plc.
Jamal Rushdy, Chief Executive Officer
Jamal brings over 20 years of experience in the medical device industry in successful entrepreneurial and high growth public companies. Jamal has extensive commercial and operational leadership experience including leading global orthopedic and biologics product marketing teams at DJO and Tornier (now Wright Medical), as well as a successful track record of building shareholder value through business development transactions. He has helped achieve successful exits for private equity and angel investors as a founding member or senior executive of four medical device companies. Jamal earned an MBA from U.C. Irvine and a BSME from U.C. San Diego.
Gill Black, Chief Financial Officer and Company Secretary
Gill Black brings her extensive, board-level financial experience to Collagen Solutions, having been financial director and company secretary at A&E Russell, where she was instrumental in their expansion before taking them through a subsequent acquisition by Bunzl in 2008. After spending two years as head of finance at AKP Scotland, she became head of finance and company secretary of GVA James Barr, a privately owned property consultancy business which merged in 2013 with top-5 UK independent, GVA Grimley. Previously, Gill was a senior manager at KPMG, Glasgow where she led a team advising many high-growth businesses. Gill holds an MA in accountancy and economics from the University of Dundee and is a Chartered Accountant and ICAS member.
Geoff Bennett, Non-Executive Director
Geoff co-founded Southern Lights Biomaterials in 2003 and as CEO was responsible for guiding the company to a dominant position in biomaterials and regenerative medicine. He has financial and operational experience including previously holding the chief financial role at three publicly traded Canadian companies (Pelorus Navigation Systems Inc., Circle Energy Inc. and Solid State Geophysical Inc.) as well as experience of early stage enterprises specialising in technology commercialisation, such as InnerVision Medical Technologies Inc. where he held the position of COO. Geoff holds a Bachelor of Commerce from the University of Alberta and is a member of the Canadian Institute of Chartered Accountants.
Malcolm Gillies, Non-Executive Director
Malcolm is a director in several private companies mostly involved in the healthcare area including Antoxis and Ohmedics. He was a non-executive director of Aircraft Medical, which was acquired by Medtronic for £72 million in November 2015. He has previously held positions as a non-executive director in public companies and was company secretary at Axis-Shield Plc. He has a background as a corporate finance lawyer, having been a senior partner with Shepherd+Wedderburn.
Page last updated: 30 June 2017